H A Bischoff-Ferrari1, E J Orav, B Dawson-Hughes. 1. Department of Rheumatology and Institute for Physical Medicine, University Hospital Zurich, Gloriastrasse, 258091, Zurich, Switzerland. hbischof@hsph.harvard.edu
Abstract
UNLABELLED: Higher physiologic testosterone levels among community dwelling older men and women may protect against falls, and this benefit may be further increased among those taking additional vitamin D plus calcium. INTRODUCTION: The aim of this study is to investigate sex hormone levels and fall risk in older men and women. METHODS: One hundred and ninety-nine men and 246 women age 65+ living at home were followed for 3 years after baseline assessment of sex hormones. Analyses controlled for several covariates, including baseline 25-hydroxyvitamin D, sex hormone binding globulin, and vitamin D plus calcium treatment (vitD+cal). RESULTS: Compared to the lowest quartile, men and women in the highest quartile of total testosterone had a decreased odds of falling (men: OR = 0.22; 95% CI [0.07,0.72]/ women: OR = 0.34; 95% CI [0.14,0.83]); if those individuals also took vitD+cal, the fall reduction was enhanced (men: OR = 0.16; 95% CI [0.03,0.90] / women: OR = 0.15; 95% CI [0.04,0.57]). Similarly, women in the top quartile of dihydroepiandrosterone sulfate (DHEA-S) had a lower risk of falling (OR = 0.39; 95% CI [0.16,0.93]). Other sex hormones and SHBG did not predict falling in men or women. CONCLUSIONS: Higher testosterone levels in both genders and higher DHEA-S levels in women predicted a more than 60% lower risk of falling. With vitD+cal, the anti-fall benefit of higher physiologic testosterone levels is enhanced from 78% to 84% among men and from 66% to 85% among women.
UNLABELLED: Higher physiologic testosterone levels among community dwelling older men and women may protect against falls, and this benefit may be further increased among those taking additional vitamin D plus calcium. INTRODUCTION: The aim of this study is to investigate sex hormone levels and fall risk in older men and women. METHODS: One hundred and ninety-nine men and 246 women age 65+ living at home were followed for 3 years after baseline assessment of sex hormones. Analyses controlled for several covariates, including baseline 25-hydroxyvitamin D, sex hormone binding globulin, and vitamin D plus calcium treatment (vitD+cal). RESULTS: Compared to the lowest quartile, men and women in the highest quartile of total testosterone had a decreased odds of falling (men: OR = 0.22; 95% CI [0.07,0.72]/ women: OR = 0.34; 95% CI [0.14,0.83]); if those individuals also took vitD+cal, the fall reduction was enhanced (men: OR = 0.16; 95% CI [0.03,0.90] / women: OR = 0.15; 95% CI [0.04,0.57]). Similarly, women in the top quartile of dihydroepiandrosterone sulfate (DHEA-S) had a lower risk of falling (OR = 0.39; 95% CI [0.16,0.93]). Other sex hormones and SHBG did not predict falling in men or women. CONCLUSIONS: Higher testosterone levels in both genders and higher DHEA-S levels in women predicted a more than 60% lower risk of falling. With vitD+cal, the anti-fall benefit of higher physiologic testosterone levels is enhanced from 78% to 84% among men and from 66% to 85% among women.
Authors: Giorgio Valenti; Licia Denti; Marcello Maggio; GianPaolo Ceda; Stefano Volpato; Stefania Bandinelli; Graziano Ceresini; Anne Cappola; Jack M Guralnik; Luigi Ferrucci Journal: J Gerontol A Biol Sci Med Sci Date: 2004-05 Impact factor: 6.053
Authors: Dennis R Taaffe; Sarianna Sipilä; Sulin Cheng; Jukka Puolakka; Jarmo Toivanen; Harri Suominen Journal: Clin Physiol Funct Imaging Date: 2005-09 Impact factor: 2.273
Authors: Dan Mellström; Olof Johnell; Osten Ljunggren; Anna-Lena Eriksson; Mattias Lorentzon; Hans Mallmin; Anna Holmberg; Inga Redlund-Johnell; Eric Orwoll; Claes Ohlsson Journal: J Bone Miner Res Date: 2006-04-05 Impact factor: 6.741
Authors: Howard A Fink; Susan K Ewing; Kristine E Ensrud; Elizabeth Barrett-Connor; Brent C Taylor; Jane A Cauley; Eric S Orwoll Journal: J Clin Endocrinol Metab Date: 2006-07-18 Impact factor: 5.958
Authors: Karen K Miller; William Rosner; Hang Lee; Joan Hier; Gemma Sesmilo; David Schoenfeld; Gregory Neubauer; Anne Klibanski Journal: J Clin Endocrinol Metab Date: 2004-02 Impact factor: 5.958
Authors: Heike A Bischoff; Hannes B Stähelin; Walter Dick; Regula Akos; Margrith Knecht; Christian Salis; Matthias Nebiker; Robert Theiler; Michael Pfeifer; Bettina Begerow; Robert A Lew; Martin Conzelmann Journal: J Bone Miner Res Date: 2003-02 Impact factor: 6.741
Authors: S R Cummings; M C Nevitt; W S Browner; K Stone; K M Fox; K E Ensrud; J Cauley; D Black; T M Vogt Journal: N Engl J Med Date: 1995-03-23 Impact factor: 91.245
Authors: Sarah E Lamb; Clemens Becker; Lesley D Gillespie; Jessica L Smith; Susanne Finnegan; Rachel Potter; Klaus Pfeiffer Journal: Trials Date: 2011-05-17 Impact factor: 2.279
Authors: J C Menant; J C T Close; K Delbaere; D L Sturnieks; J Trollor; P S Sachdev; H Brodaty; S R Lord Journal: Osteoporos Int Date: 2011-04-20 Impact factor: 4.507
Authors: B Dawson-Hughes; C Castaneda-Sceppa; S S Harris; N J Palermo; G Cloutier; L Ceglia; G E Dallal Journal: Osteoporos Int Date: 2009-09-01 Impact factor: 4.507
Authors: Lesley D Gillespie; M Clare Robertson; William J Gillespie; Catherine Sherrington; Simon Gates; Lindy M Clemson; Sarah E Lamb Journal: Cochrane Database Syst Rev Date: 2012-09-12